{"id":48079,"date":"2022-09-07T22:01:56","date_gmt":"2022-09-07T20:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/"},"modified":"2022-09-07T22:01:56","modified_gmt":"2022-09-07T20:01:56","slug":"urogen-pharma-announces-upcoming-2022-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/","title":{"rendered":"UroGen Pharma Announces Upcoming 2022 Conferences"},"content":{"rendered":"<div>\n<p>PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following healthcare conferences in September:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/5\/UroGen_logo2_%281%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/21\/UroGen_logo2_%281%29.jpg\"><\/a><\/p>\n<p>\nH.C. Wainwright &amp; Co. Annual Global Investment Conference\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nTuesday, September 13 at 10:30 a.m. ET\n<\/li>\n<\/ul>\n<p>\nLadenburg Thalmann Healthcare Conference\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAnalyst Discussion on Thursday, September 29 at 8:30 a.m. ET\n<\/li>\n<\/ul>\n<p>\nWebcasts of both the H.C. Wainwright &amp; Co. and Ladenburg Thalmann presentations will be available via the Investors section of UroGen\u2019s website, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.urogen.com&amp;esheet=52867161&amp;newsitemid=20220907006069&amp;lan=en-US&amp;anchor=www.urogen.com&amp;index=1&amp;md5=8be2ded1181f03212251ecf851091cd1\" rel=\"nofollow noopener\" shape=\"rect\">www.urogen.com<\/a>. A replay of each webcast will be available on the Company\u2019s website for approximately 30 days.\n<\/p>\n<p>\n<b>About UroGen Pharma Ltd.<\/b>\n<\/p>\n<p>\nUroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel\u2122 reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen\u2019s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. Jelmyto\u00ae (mitomycin) for pyelocaliceal solution and investigational treatment UGN-102 (mitomycin) for intravesical solution are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.urogen.com&amp;esheet=52867161&amp;newsitemid=20220907006069&amp;lan=en-US&amp;anchor=www.urogen.com&amp;index=2&amp;md5=7e915ceee9eaf75f812697973630b7b1\" rel=\"nofollow noopener\" shape=\"rect\">www.urogen.com<\/a> to learn more or follow us on Twitter, @UroGenPharma.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>INVESTOR CONTACT:<\/b><br \/>Vincent Perrone<br \/>\n<br \/>Senior Director, Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x76;i&#110;&#x63;e&#110;&#x74;&#46;&#112;&#x65;r&#114;&#x6f;n&#101;&#x40;u&#114;&#x6f;g&#101;&#x6e;&#46;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">vi&#110;&#99;&#101;&#x6e;&#x74;&#x2e;&#x70;&#x65;rr&#111;&#110;&#101;&#x40;&#x75;&#x72;&#x6f;&#x67;en&#46;&#99;&#111;&#x6d;<\/a><br \/>609-460-3588 ext. 1093\n<\/p>\n<p>\n<b>MEDIA CONTACT:<\/b><br \/>Cindy Romano<br \/>\n<br \/>UroGen Corporate Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x63;i&#x6e;&#100;&#x79;&#46;r&#x6f;&#109;&#x61;&#110;o&#x40;u&#x72;&#111;&#x67;&#101;n&#x2e;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#99;&#x69;&#110;&#x64;y&#46;&#x72;&#111;&#x6d;a&#x6e;o&#64;&#x75;&#114;&#x6f;g&#x65;&#x6e;&#46;&#x63;o&#x6d;<\/a><br \/>908-963-7827\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following healthcare conferences in September: H.C. Wainwright &amp; Co. Annual Global Investment Conference Tuesday, September 13 at 10:30 a.m. ET Ladenburg Thalmann Healthcare Conference &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48079","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UroGen Pharma Announces Upcoming 2022 Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UroGen Pharma Announces Upcoming 2022 Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following healthcare conferences in September: H.C. Wainwright &amp; Co. Annual Global Investment Conference Tuesday, September 13 at 10:30 a.m. ET Ladenburg Thalmann Healthcare Conference ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-07T20:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/21\/UroGen_logo2_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"UroGen Pharma Announces Upcoming 2022 Conferences\",\"datePublished\":\"2022-09-07T20:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/\"},\"wordCount\":267,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006069\\\/en\\\/1564292\\\/21\\\/UroGen_logo2_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/\",\"name\":\"UroGen Pharma Announces Upcoming 2022 Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006069\\\/en\\\/1564292\\\/21\\\/UroGen_logo2_%281%29.jpg\",\"datePublished\":\"2022-09-07T20:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006069\\\/en\\\/1564292\\\/21\\\/UroGen_logo2_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006069\\\/en\\\/1564292\\\/21\\\/UroGen_logo2_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-announces-upcoming-2022-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UroGen Pharma Announces Upcoming 2022 Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UroGen Pharma Announces Upcoming 2022 Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/","og_locale":"en_US","og_type":"article","og_title":"UroGen Pharma Announces Upcoming 2022 Conferences - Pharma Trend","og_description":"PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following healthcare conferences in September: H.C. Wainwright &amp; Co. Annual Global Investment Conference Tuesday, September 13 at 10:30 a.m. ET Ladenburg Thalmann Healthcare Conference ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-07T20:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/21\/UroGen_logo2_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"UroGen Pharma Announces Upcoming 2022 Conferences","datePublished":"2022-09-07T20:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/"},"wordCount":267,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/21\/UroGen_logo2_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/","url":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/","name":"UroGen Pharma Announces Upcoming 2022 Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/21\/UroGen_logo2_%281%29.jpg","datePublished":"2022-09-07T20:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/21\/UroGen_logo2_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220907006069\/en\/1564292\/21\/UroGen_logo2_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-announces-upcoming-2022-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"UroGen Pharma Announces Upcoming 2022 Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48079"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48079\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}